Optimer Reviews

Recommend to a friend
Approve of CEO
Optimer President, CEO, and Director S. Pedro Lichtinger
S. Pedro Lichtinger
2 Ratings
  • Helpful (2)


    • Work/Life Balance
    • Culture & Values
    • Career Opportunities
    • Comp & Benefits
    • Senior Management
    Current Employee - Anonymous Employee
    Current Employee - Anonymous Employee

    I have been working at Optimer

    Doesn't Recommend
    Negative Outlook
    Disapproves of CEO
    Doesn't Recommend
    Negative Outlook
    Disapproves of CEO


    None to speak of at all


    Everything about this company is dirgraceful

    Advice to Management

    Resign in disgrace

Optimer Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Website www.optimerpharma.com
Headquarters San Diego, CA
Size 150 to 499 Employees
Founded 1999
Type Company - Public
Industry Biotech & Pharmaceuticals
Revenue $50 to $100 million (USD) per year
Competitors Pfizer, Bayer, Sanofi-Aventis

Optimer Pharmaceuticals has good reason to be optimistic: its lead drug Fidaxomicin kills a wicked and persistent bacteria better than anything else. Presented under the market name Dificid, Fidaxomicin has been approved for treating Clostridium difficile-associated diarrhea, commonly acquired in hospitals. Its Pruvel antibiotic is also in late-stage clinical trials for the treatment of infectious traveler's diarrhea. Through the manipulation of carbohydrates, the company is using its OPopS technology to identify other potential drug candidates for diseases such as breast... More

Work at Optimer? Share Your Experiences


Click to Rate